SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
First-generation antihistamines increase delirium risk in older hospitalized patients
An analysis in the Journal of the American Geriatrics Society reveals that older inpatients admitted to physicians who…